This company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsFile Forge Technology（FILE）株式概要ファイル・フォージ・テクノロジーは重要な事業を行っていない。 詳細FILE ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6リスク分析収益が 100 万ドル未満 ( £0 )意味のある時価総額がありません ( £229K )UK市場と比較して、過去 3 か月間の株価の変動が非常に大きい最新の財務報告は6か月以上前のものである すべてのリスクチェックを見るFILE Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUK£Current PriceUK£0.018該当なし内在価値ディスカウントEst. Revenue$PastFuture-1m12016201920222025202620282031Revenue UK£1.0Earnings UK£0.3AdvancedSet Fair ValueView all narrativesFile Forge Technology Plc 競合他社EvrimaSymbol: OFEX:EVAMarket cap: UK£276.1kGledhow InvestmentsSymbol: OFEX:GDHMarket cap: UK£440.3kEthtrySymbol: OFEX:ETHYMarket cap: UK£4.5mAura Renewable AcquisitionsSymbol: LSE:ARAMarket cap: UK£210.0k価格と性能株価の高値、安値、推移の概要File Forge Technology過去の株価現在の株価UK£0.01852週高値UK£052週安値UK£0ベータ-0.231ヶ月の変化10.13%3ヶ月変化10.13%1年変化10.13%3年間の変化-93.30%5年間の変化n/aIPOからの変化-97.27%最新ニュースお知らせ • Jun 06Amirose London Limited completed the acquisition of File Forge Technology Plc (OFEX:FILE) in a reverse merger transaction.Amirose London Limited signed non-binding Heads of Terms to acquire File Forge Technology Plc (OFEX:FILE) for £0.07 million in a reverse merger transaction on March 20, 2025. The consideration consists of common equity of File Forge Technology Plc having a value of £5.01 million to be issued for common equity of Amirose London Limited. As part of consideration, £5.01 million is paid towards common equity of Amirose London Limited. Amirose London Limited executed a share purchase agreement to acquire File Forge Technology Plc (OFEX:FILE) for £0.07 million in a reverse merger transaction on April 25, 2025. File Forge has issued 100.190739 million shares to the shareholders of Amirose for £0.05 per New Ordinary Share. Amirose is seeking a listing on the Aquis Stock Exchange Growth Market via the reverse takeover in order to facilitate investments by investors and raise its profile with existing and future customers. Under the terms of the Acquisition Agreement, the Company will acquire Amirose through the issue of the Consideration Shares at an agreed valuation of £5,009,536. The Acquisition is conditional, inter alia, on the approval at the Extraordinary General Meeting of: i. the Waiver Resolution; ii. the Resolution to approve the Acquisition; and iii. the Resolutions to authorize the issue of the Consideration Shares and the Subscription Shares. Pursuant to the Acquisition and conditional on the approval of the Resolutions, all Directors will resign, and the Proposed Directors will be appointed on Admission. Michael Heath, Chief Executive Director, Aleksandra Binkowska, Non-Executive Chairperson, Mitchell Field, Non-Executive Director and David Battle, Independent Non-Executive Director. The Company has agreed with the Panel that Howard White, Ben White, Aleksandra Binkowska and Mitchell Field are ‘acting in concert’ in relation to the proposed acquisition by the Company of Amirose. Completion of the Acquisition was made subject to and conditional upon the satisfaction of certain conditions such conditions are required to be satisfied by no later than the long stop date, which has been agreed to be June 30, 2025. The transaction is subject to approval of offer by File Forge shareholders. It is expected that upon completion of the Proposed Acquisition, File Forge's name will be changed to Amirose London Holdings PLC. As of May 16, 2025 File Forge Technology's shareholder approved the transaction. As of May 21, 2025, On Admission, File Forge Technology PLC is to change its name to Amirose London Holdings PLC. Alfred Henry Corporate Finance Limited acted as financial advisor to File Forge Technology Plc and has charged £50,000 as advisor fees in the transaction. Glaisyers Solicitors LLP acted as legal advisor to File Forge Technology Plc. Computershare Investors Services (BVI) Ltd. Acted as registrar to File Forge Technology Plc. Amirose London Limited completed the acquisition of File Forge Technology Plc (OFEX:FILE) in a reverse merger transaction on June 6, 2025. The Company's change of name to Amirose London Holdings PLC will be effective once Companies House has issued a new certificate of incorporation reflecting the change of name. The ticker 'ALH' is effective immediately. From 9 June 2025, the Company's enlarged issued ordinary share capital will comprise 118,783,865 Ordinary Shares.お知らせ • Mar 21File Forge Technology Plc (OFEX:FILE) signed a letter of intent to acquire Amirose London Limited from Epoque Services Incorporated Limited for £5 million.File Forge Technology Plc (OFEX:FILE) signed non-binding Heads of Terms to acquire Amirose London Limited from Epoque Services Incorporated Limited for £5 million on March 20, 2025. The consideration consists of common equity of File Forge Technology Plc having a value of £5.01 million to be issued for common equity of Amirose London Limited. As part of consideration, £5.01 million is paid towards common equity of Amirose London Limited. The transaction is subject to approval of offer by File Forge shareholders. It is expected that upon completion of the Proposed Acquisition, File Forge's name will be changed to Amirose London Holdings PLC.New Risk • Mar 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (UK£208.0k market cap, or US$269.1k). Minor Risk Latest financial reports are more than 6 months old (reported May 2024 fiscal period end).お知らせ • May 25Clarify Pharma PLC, Annual General Meeting, Jun 24, 2024Clarify Pharma PLC, Annual General Meeting, Jun 24, 2024. Location: the offices of fladgate llp, 16 great queen street, england, wc2b 5dg, london United KingdomNew Risk • Mar 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (UK£683.6k market cap, or US$870.4k). Minor Risk Latest financial reports are more than 6 months old (reported May 2023 fiscal period end).お知らせ • Jun 14Clarify Pharma PLC, Annual General Meeting, Jul 05, 2023Clarify Pharma PLC, Annual General Meeting, Jul 05, 2023, at 10:00 Coordinated Universal Time. Location: at the offices of Lomas & Co, Bridge House, 12 Market Street, Glossop, Derbyshire SK13 8AR London United Kingdom最新情報をもっと見るRecent updatesお知らせ • Jun 06Amirose London Limited completed the acquisition of File Forge Technology Plc (OFEX:FILE) in a reverse merger transaction.Amirose London Limited signed non-binding Heads of Terms to acquire File Forge Technology Plc (OFEX:FILE) for £0.07 million in a reverse merger transaction on March 20, 2025. The consideration consists of common equity of File Forge Technology Plc having a value of £5.01 million to be issued for common equity of Amirose London Limited. As part of consideration, £5.01 million is paid towards common equity of Amirose London Limited. Amirose London Limited executed a share purchase agreement to acquire File Forge Technology Plc (OFEX:FILE) for £0.07 million in a reverse merger transaction on April 25, 2025. File Forge has issued 100.190739 million shares to the shareholders of Amirose for £0.05 per New Ordinary Share. Amirose is seeking a listing on the Aquis Stock Exchange Growth Market via the reverse takeover in order to facilitate investments by investors and raise its profile with existing and future customers. Under the terms of the Acquisition Agreement, the Company will acquire Amirose through the issue of the Consideration Shares at an agreed valuation of £5,009,536. The Acquisition is conditional, inter alia, on the approval at the Extraordinary General Meeting of: i. the Waiver Resolution; ii. the Resolution to approve the Acquisition; and iii. the Resolutions to authorize the issue of the Consideration Shares and the Subscription Shares. Pursuant to the Acquisition and conditional on the approval of the Resolutions, all Directors will resign, and the Proposed Directors will be appointed on Admission. Michael Heath, Chief Executive Director, Aleksandra Binkowska, Non-Executive Chairperson, Mitchell Field, Non-Executive Director and David Battle, Independent Non-Executive Director. The Company has agreed with the Panel that Howard White, Ben White, Aleksandra Binkowska and Mitchell Field are ‘acting in concert’ in relation to the proposed acquisition by the Company of Amirose. Completion of the Acquisition was made subject to and conditional upon the satisfaction of certain conditions such conditions are required to be satisfied by no later than the long stop date, which has been agreed to be June 30, 2025. The transaction is subject to approval of offer by File Forge shareholders. It is expected that upon completion of the Proposed Acquisition, File Forge's name will be changed to Amirose London Holdings PLC. As of May 16, 2025 File Forge Technology's shareholder approved the transaction. As of May 21, 2025, On Admission, File Forge Technology PLC is to change its name to Amirose London Holdings PLC. Alfred Henry Corporate Finance Limited acted as financial advisor to File Forge Technology Plc and has charged £50,000 as advisor fees in the transaction. Glaisyers Solicitors LLP acted as legal advisor to File Forge Technology Plc. Computershare Investors Services (BVI) Ltd. Acted as registrar to File Forge Technology Plc. Amirose London Limited completed the acquisition of File Forge Technology Plc (OFEX:FILE) in a reverse merger transaction on June 6, 2025. The Company's change of name to Amirose London Holdings PLC will be effective once Companies House has issued a new certificate of incorporation reflecting the change of name. The ticker 'ALH' is effective immediately. From 9 June 2025, the Company's enlarged issued ordinary share capital will comprise 118,783,865 Ordinary Shares.お知らせ • Mar 21File Forge Technology Plc (OFEX:FILE) signed a letter of intent to acquire Amirose London Limited from Epoque Services Incorporated Limited for £5 million.File Forge Technology Plc (OFEX:FILE) signed non-binding Heads of Terms to acquire Amirose London Limited from Epoque Services Incorporated Limited for £5 million on March 20, 2025. The consideration consists of common equity of File Forge Technology Plc having a value of £5.01 million to be issued for common equity of Amirose London Limited. As part of consideration, £5.01 million is paid towards common equity of Amirose London Limited. The transaction is subject to approval of offer by File Forge shareholders. It is expected that upon completion of the Proposed Acquisition, File Forge's name will be changed to Amirose London Holdings PLC.New Risk • Mar 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (UK£208.0k market cap, or US$269.1k). Minor Risk Latest financial reports are more than 6 months old (reported May 2024 fiscal period end).お知らせ • May 25Clarify Pharma PLC, Annual General Meeting, Jun 24, 2024Clarify Pharma PLC, Annual General Meeting, Jun 24, 2024. Location: the offices of fladgate llp, 16 great queen street, england, wc2b 5dg, london United KingdomNew Risk • Mar 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (UK£683.6k market cap, or US$870.4k). Minor Risk Latest financial reports are more than 6 months old (reported May 2023 fiscal period end).お知らせ • Jun 14Clarify Pharma PLC, Annual General Meeting, Jul 05, 2023Clarify Pharma PLC, Annual General Meeting, Jul 05, 2023, at 10:00 Coordinated Universal Time. Location: at the offices of Lomas & Co, Bridge House, 12 Market Street, Glossop, Derbyshire SK13 8AR London United KingdomBoard Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. was the last director to join the board, commencing their role in . The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 07Clarify Pharma PLC, Annual General Meeting, May 30, 2022Clarify Pharma PLC, Annual General Meeting, May 30, 2022, at 10:00 Coordinated Universal Time. Location: offices of Fladgate LLP, 16 Great Queen Street London United Kingdom株主還元FILEGB Capital MarketsGB 市場7D0%3.4%2.5%1Y10.1%-7.2%19.4%株主還元を見る業界別リターン: FILE過去 1 年間で-7.2 % の収益を上げたUK Capital Markets業界を下回りました。リターン対市場: FILE過去 1 年間で19.4 % の収益を上げたUK市場を上回りました。価格変動Is FILE's price volatile compared to industry and market?FILE volatilityFILE Average Weekly Movement723.1%Capital Markets Industry Average Movement4.6%Market Average Movement5.7%10% most volatile stocks in GB Market12.0%10% least volatile stocks in GB Market3.0%安定した株価: FILEの株価は、 UK市場と比較して過去 3 か月間で変動しています。時間の経過による変動: FILEの 週次ボラティリティ は、過去 1 年間で358%から723%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイト20195n/awww.getfileforge.comファイル・フォージ・テクノロジー社は重要な事業を行っていない。ヘルスケア、IT、臨床サイケデリック企業のポートフォリオに注力している。File Forge Technology Plcは2019年に法人化され、英国ロンドンに拠点を置く。もっと見るFile Forge Technology Plc 基礎のまとめFile Forge Technology の収益と売上を時価総額と比較するとどうか。FILE 基礎統計学時価総額UK£229.09k収益（TTM）-UK£645.00k売上高(TTM)n/a0.0xP/Sレシオ-0.4xPER（株価収益率FILE は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計FILE 損益計算書（TTM）収益UK£0売上原価UK£0売上総利益UK£0その他の費用UK£645.00k収益-UK£645.00k直近の収益報告May 31, 2024次回決算日該当なし一株当たり利益（EPS）-0.052グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0%FILE の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/06/05 16:33終値2025/06/05 00:00収益2024/05/31年間収益2023/11/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋File Forge Technology Plc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 06Amirose London Limited completed the acquisition of File Forge Technology Plc (OFEX:FILE) in a reverse merger transaction.Amirose London Limited signed non-binding Heads of Terms to acquire File Forge Technology Plc (OFEX:FILE) for £0.07 million in a reverse merger transaction on March 20, 2025. The consideration consists of common equity of File Forge Technology Plc having a value of £5.01 million to be issued for common equity of Amirose London Limited. As part of consideration, £5.01 million is paid towards common equity of Amirose London Limited. Amirose London Limited executed a share purchase agreement to acquire File Forge Technology Plc (OFEX:FILE) for £0.07 million in a reverse merger transaction on April 25, 2025. File Forge has issued 100.190739 million shares to the shareholders of Amirose for £0.05 per New Ordinary Share. Amirose is seeking a listing on the Aquis Stock Exchange Growth Market via the reverse takeover in order to facilitate investments by investors and raise its profile with existing and future customers. Under the terms of the Acquisition Agreement, the Company will acquire Amirose through the issue of the Consideration Shares at an agreed valuation of £5,009,536. The Acquisition is conditional, inter alia, on the approval at the Extraordinary General Meeting of: i. the Waiver Resolution; ii. the Resolution to approve the Acquisition; and iii. the Resolutions to authorize the issue of the Consideration Shares and the Subscription Shares. Pursuant to the Acquisition and conditional on the approval of the Resolutions, all Directors will resign, and the Proposed Directors will be appointed on Admission. Michael Heath, Chief Executive Director, Aleksandra Binkowska, Non-Executive Chairperson, Mitchell Field, Non-Executive Director and David Battle, Independent Non-Executive Director. The Company has agreed with the Panel that Howard White, Ben White, Aleksandra Binkowska and Mitchell Field are ‘acting in concert’ in relation to the proposed acquisition by the Company of Amirose. Completion of the Acquisition was made subject to and conditional upon the satisfaction of certain conditions such conditions are required to be satisfied by no later than the long stop date, which has been agreed to be June 30, 2025. The transaction is subject to approval of offer by File Forge shareholders. It is expected that upon completion of the Proposed Acquisition, File Forge's name will be changed to Amirose London Holdings PLC. As of May 16, 2025 File Forge Technology's shareholder approved the transaction. As of May 21, 2025, On Admission, File Forge Technology PLC is to change its name to Amirose London Holdings PLC. Alfred Henry Corporate Finance Limited acted as financial advisor to File Forge Technology Plc and has charged £50,000 as advisor fees in the transaction. Glaisyers Solicitors LLP acted as legal advisor to File Forge Technology Plc. Computershare Investors Services (BVI) Ltd. Acted as registrar to File Forge Technology Plc. Amirose London Limited completed the acquisition of File Forge Technology Plc (OFEX:FILE) in a reverse merger transaction on June 6, 2025. The Company's change of name to Amirose London Holdings PLC will be effective once Companies House has issued a new certificate of incorporation reflecting the change of name. The ticker 'ALH' is effective immediately. From 9 June 2025, the Company's enlarged issued ordinary share capital will comprise 118,783,865 Ordinary Shares.
お知らせ • Mar 21File Forge Technology Plc (OFEX:FILE) signed a letter of intent to acquire Amirose London Limited from Epoque Services Incorporated Limited for £5 million.File Forge Technology Plc (OFEX:FILE) signed non-binding Heads of Terms to acquire Amirose London Limited from Epoque Services Incorporated Limited for £5 million on March 20, 2025. The consideration consists of common equity of File Forge Technology Plc having a value of £5.01 million to be issued for common equity of Amirose London Limited. As part of consideration, £5.01 million is paid towards common equity of Amirose London Limited. The transaction is subject to approval of offer by File Forge shareholders. It is expected that upon completion of the Proposed Acquisition, File Forge's name will be changed to Amirose London Holdings PLC.
New Risk • Mar 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (UK£208.0k market cap, or US$269.1k). Minor Risk Latest financial reports are more than 6 months old (reported May 2024 fiscal period end).
お知らせ • May 25Clarify Pharma PLC, Annual General Meeting, Jun 24, 2024Clarify Pharma PLC, Annual General Meeting, Jun 24, 2024. Location: the offices of fladgate llp, 16 great queen street, england, wc2b 5dg, london United Kingdom
New Risk • Mar 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (UK£683.6k market cap, or US$870.4k). Minor Risk Latest financial reports are more than 6 months old (reported May 2023 fiscal period end).
お知らせ • Jun 14Clarify Pharma PLC, Annual General Meeting, Jul 05, 2023Clarify Pharma PLC, Annual General Meeting, Jul 05, 2023, at 10:00 Coordinated Universal Time. Location: at the offices of Lomas & Co, Bridge House, 12 Market Street, Glossop, Derbyshire SK13 8AR London United Kingdom
お知らせ • Jun 06Amirose London Limited completed the acquisition of File Forge Technology Plc (OFEX:FILE) in a reverse merger transaction.Amirose London Limited signed non-binding Heads of Terms to acquire File Forge Technology Plc (OFEX:FILE) for £0.07 million in a reverse merger transaction on March 20, 2025. The consideration consists of common equity of File Forge Technology Plc having a value of £5.01 million to be issued for common equity of Amirose London Limited. As part of consideration, £5.01 million is paid towards common equity of Amirose London Limited. Amirose London Limited executed a share purchase agreement to acquire File Forge Technology Plc (OFEX:FILE) for £0.07 million in a reverse merger transaction on April 25, 2025. File Forge has issued 100.190739 million shares to the shareholders of Amirose for £0.05 per New Ordinary Share. Amirose is seeking a listing on the Aquis Stock Exchange Growth Market via the reverse takeover in order to facilitate investments by investors and raise its profile with existing and future customers. Under the terms of the Acquisition Agreement, the Company will acquire Amirose through the issue of the Consideration Shares at an agreed valuation of £5,009,536. The Acquisition is conditional, inter alia, on the approval at the Extraordinary General Meeting of: i. the Waiver Resolution; ii. the Resolution to approve the Acquisition; and iii. the Resolutions to authorize the issue of the Consideration Shares and the Subscription Shares. Pursuant to the Acquisition and conditional on the approval of the Resolutions, all Directors will resign, and the Proposed Directors will be appointed on Admission. Michael Heath, Chief Executive Director, Aleksandra Binkowska, Non-Executive Chairperson, Mitchell Field, Non-Executive Director and David Battle, Independent Non-Executive Director. The Company has agreed with the Panel that Howard White, Ben White, Aleksandra Binkowska and Mitchell Field are ‘acting in concert’ in relation to the proposed acquisition by the Company of Amirose. Completion of the Acquisition was made subject to and conditional upon the satisfaction of certain conditions such conditions are required to be satisfied by no later than the long stop date, which has been agreed to be June 30, 2025. The transaction is subject to approval of offer by File Forge shareholders. It is expected that upon completion of the Proposed Acquisition, File Forge's name will be changed to Amirose London Holdings PLC. As of May 16, 2025 File Forge Technology's shareholder approved the transaction. As of May 21, 2025, On Admission, File Forge Technology PLC is to change its name to Amirose London Holdings PLC. Alfred Henry Corporate Finance Limited acted as financial advisor to File Forge Technology Plc and has charged £50,000 as advisor fees in the transaction. Glaisyers Solicitors LLP acted as legal advisor to File Forge Technology Plc. Computershare Investors Services (BVI) Ltd. Acted as registrar to File Forge Technology Plc. Amirose London Limited completed the acquisition of File Forge Technology Plc (OFEX:FILE) in a reverse merger transaction on June 6, 2025. The Company's change of name to Amirose London Holdings PLC will be effective once Companies House has issued a new certificate of incorporation reflecting the change of name. The ticker 'ALH' is effective immediately. From 9 June 2025, the Company's enlarged issued ordinary share capital will comprise 118,783,865 Ordinary Shares.
お知らせ • Mar 21File Forge Technology Plc (OFEX:FILE) signed a letter of intent to acquire Amirose London Limited from Epoque Services Incorporated Limited for £5 million.File Forge Technology Plc (OFEX:FILE) signed non-binding Heads of Terms to acquire Amirose London Limited from Epoque Services Incorporated Limited for £5 million on March 20, 2025. The consideration consists of common equity of File Forge Technology Plc having a value of £5.01 million to be issued for common equity of Amirose London Limited. As part of consideration, £5.01 million is paid towards common equity of Amirose London Limited. The transaction is subject to approval of offer by File Forge shareholders. It is expected that upon completion of the Proposed Acquisition, File Forge's name will be changed to Amirose London Holdings PLC.
New Risk • Mar 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (UK£208.0k market cap, or US$269.1k). Minor Risk Latest financial reports are more than 6 months old (reported May 2024 fiscal period end).
お知らせ • May 25Clarify Pharma PLC, Annual General Meeting, Jun 24, 2024Clarify Pharma PLC, Annual General Meeting, Jun 24, 2024. Location: the offices of fladgate llp, 16 great queen street, england, wc2b 5dg, london United Kingdom
New Risk • Mar 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (UK£683.6k market cap, or US$870.4k). Minor Risk Latest financial reports are more than 6 months old (reported May 2023 fiscal period end).
お知らせ • Jun 14Clarify Pharma PLC, Annual General Meeting, Jul 05, 2023Clarify Pharma PLC, Annual General Meeting, Jul 05, 2023, at 10:00 Coordinated Universal Time. Location: at the offices of Lomas & Co, Bridge House, 12 Market Street, Glossop, Derbyshire SK13 8AR London United Kingdom
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. was the last director to join the board, commencing their role in . The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 07Clarify Pharma PLC, Annual General Meeting, May 30, 2022Clarify Pharma PLC, Annual General Meeting, May 30, 2022, at 10:00 Coordinated Universal Time. Location: offices of Fladgate LLP, 16 Great Queen Street London United Kingdom
